These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16678710)

  • 1. Pretreatment with dextran 1 makes dextran 40 therapy safer.
    Ljungström KG
    J Vasc Surg; 2006 May; 43(5):1070-2. PubMed ID: 16678710
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextran 40 therapy made safer by pretreatment with dextran 1.
    Ljungström KG
    Plast Reconstr Surg; 2007 Jul; 120(1):337-340. PubMed ID: 17572583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risks of infusion of colloidal solutions].
    Messmer K
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):284-5. PubMed ID: 7511447
    [No Abstract]   [Full Text] [Related]  

  • 4. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1.
    Ljungström KG; Willman B; Hedin H
    Ann Fr Anesth Reanim; 1993; 12(2):219-22. PubMed ID: 7690207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of dextran in relation to other colloids--ten years experience with hapten inhibition.
    Ljungström KG
    Infusionsther Transfusionsmed; 1993 Oct; 20(5):206-10. PubMed ID: 7508309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
    Allhoff T; Lenhart FP
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):301-6. PubMed ID: 7511449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of allergic dextran reactions by premedication of 20 ml hapten in 12,000 patients in Switzerland].
    Gruber UF; Wettler H; Allemann U; Gerber H; Laubenthal H; Messmer K
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):269-70. PubMed ID: 6188142
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man.
    Hedin H; Richter W
    Int Arch Allergy Appl Immunol; 1982; 68(2):122-6. PubMed ID: 6176555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of dextran anaphylaxis].
    Laubenthal H; Peter K; Messmer K
    MMW Munch Med Wochenschr; 1982 Oct; 124(43):951-3. PubMed ID: 6183584
    [No Abstract]   [Full Text] [Related]  

  • 10. Hapten inhibition and dextran anaphylaxis.
    Ljungström KG; Renck H; Hedin H; Richter W; Wiholm BE
    Anaesthesia; 1988 Sep; 43(9):729-32. PubMed ID: 2459986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrodex/Rheomacrodex. Prevention of adverse effects].
    Ljungström KG; Ulseth E; Lilleaasen P
    Tidsskr Nor Laegeforen; 1986 Jan; 106(2):129-31. PubMed ID: 2420021
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of dextran-induced anaphylactoid reactions by hapten inhibition.
    Messmer K; Ljungstrom KG; Gruber UF; Richter W; Hedin H
    Lancet; 1980 May; 1(8175):975. PubMed ID: 6154846
    [No Abstract]   [Full Text] [Related]  

  • 13. Probable grade IV dextran-induced anaphylactic reaction despite hapten inhibition.
    Bircher AJ; Hédin H; Berglund A
    J Allergy Clin Immunol; 1995 Feb; 95(2):633-4. PubMed ID: 7531733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of dextran anaphylaxis using hapten dextran].
    Comberg HU
    Dtsch Med Wochenschr; 1984 Jan; 109(1):36-8. PubMed ID: 6198137
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of complement in anaphylactoid reactions in connection with infusion of dextran.
    Johnson U; Laurell AB
    Scand J Immunol; 1974; 3(5):673-6. PubMed ID: 4214504
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Hedin H; Richter W
    Acta Chir Scand; 1983; 149(4):355-60. PubMed ID: 6193667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Rosberg B; Dhunér KG; Dahl S
    Acta Chir Scand; 1983; 149(4):349-53. PubMed ID: 6193666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological studies on the adverse effects of dextran].
    Richter W
    Klin Anasthesiol Intensivther; 1975; 9():48-57. PubMed ID: 1234607
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of dextran anaphylaxis. Ten years experience with hapten dextran.
    Hedin H; Ljungström KG
    Int Arch Allergy Immunol; 1997; 113(1-3):358-9. PubMed ID: 9130577
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.
    Ljungström KG; Renck H; Hedin H; Richter W; Rosberg B
    Acta Chir Scand; 1983; 149(4):341-8. PubMed ID: 6193665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.